DMIIR
Drugs Made In America Acquisition II Corp.Rights of Drugs Made In America Acquisition II Corp. · DMII stock page →
—
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| Clear Street Group Inc. | DOUBLED | $23.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jul 31, 2026 Short interest report
Short Interest: DMIIR up 11% to 0.0M shares
Settlement 2026-07-31 | Days to cover: 11.09
Jun 30, 2026 Inst.
Apr 28, 2026 SEC Clear Street Group Inc. — DOUBLED
297,716 shares ($23.8K)
Drugs Made In America Acquisition II Corp. (DMIIR) formalized compensation for its CEO and updated the CFO's…
8-K — Impact 2/10
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 neutralAll DMIIR filing & press-release reports (1)
- 8-K reportApr 28, 2026